.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cantor Fitzgerald
Johnson and Johnson
Farmers Insurance
Dow
US Department of Justice
McKesson
Express Scripts
Queensland Health
Novartis
Baxter

Generated: September 19, 2017

DrugPatentWatch Database Preview

CREON Drug Profile

« Back to Dashboard

What is the patent landscape for Creon, and when can generic versions of Creon launch?

Creon is a drug marketed by Abbvie and is included in one NDA. There is one patent protecting this drug.

This drug has forty-two patent family members in twenty-two countries.

The generic ingredient in CREON is pancrelipase (amylase;lipase;protease). There are six drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the pancrelipase (amylase;lipase;protease) profile page.

Summary for Tradename: CREON

Patents:1
Applicants:1
NDAs:1
Suppliers / Packagers: see list3
Clinical Trials: see list14
Drug Prices:see details
DailyMed Link:CREON at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbvie
CREON
pancrelipase (amylase;lipase;protease)
CAPSULE, DELAYED RELEASE;ORAL020725-002Apr 30, 2009RXYesNo► Subscribe► SubscribeY ► Subscribe
Abbvie
CREON
pancrelipase (amylase;lipase;protease)
CAPSULE, DELAYED RELEASE;ORAL020725-003Apr 30, 2009RXYesYes► Subscribe► SubscribeY ► Subscribe
Abbvie
CREON
pancrelipase (amylase;lipase;protease)
CAPSULE, DELAYED RELEASE;ORAL020725-001Apr 30, 2009RXYesNo► Subscribe► SubscribeY ► Subscribe
Abbvie
CREON
pancrelipase (amylase;lipase;protease)
CAPSULE, DELAYED RELEASE;ORAL020725-004Jul 12, 2011RXYesNo► Subscribe► SubscribeY ► Subscribe
Abbvie
CREON
pancrelipase (amylase;lipase;protease)
CAPSULE, DELAYED RELEASE;ORAL020725-004Jul 12, 2011RXYesNo► Subscribe► Subscribe► Subscribe
Abbvie
CREON
pancrelipase (amylase;lipase;protease)
CAPSULE, DELAYED RELEASE;ORAL020725-005Mar 14, 2013RXYesNo► Subscribe► Subscribe► Subscribe
Abbvie
CREON
pancrelipase (amylase;lipase;protease)
CAPSULE, DELAYED RELEASE;ORAL020725-005Mar 14, 2013RXYesNo► Subscribe► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tradename: CREON

Country Document Number Estimated Expiration
Japan2009504710► Subscribe
Canada2619477► Subscribe
Japan5452918► Subscribe
Germany602006012346► Subscribe
Austria457719► Subscribe
European Patent Office1931316► Subscribe
World Intellectual Property Organization (WIPO)2007020260► Subscribe
Hong Kong1121037► Subscribe
Russian Federation2008109652► Subscribe
Russian Federation2440101► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Baxter
Healthtrust
McKesson
Citi
AstraZeneca
Chubb
Novartis
Queensland Health
Boehringer Ingelheim
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot